Skip to content
Screener

Charles River Laboratories CRL Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$178K-42.8%
Sotera Health logo
Sotera HealthSHC
$40.63M+3.4%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$1.32M-97.2%
Revvity logo
RevvityRVTY
$309.11M-3.7%
Labcorp Holdings logo
Labcorp HoldingsLH
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$13.22B+80.4%
Enterprise value$16.03B+60.9%
P/S3.3×+1.5×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026December 27, 2025
Goodwill3,076,8512,764,253
Intangible assets, net253,174339,995
Deferred tax assets53,82767,334
Other assets587,556293,185
Total assets$7,532,145$7,135,422
Liabilities, Redeemable Noncontrolling Interests and Equity
Current liabilities:
Accounts payable$140,983$148,800

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's deferred tax assets and other non-current assets?
Charles River Laboratories (CRL) reported deferred tax assets and other non-current assets of $587.56M in Q2 2026.
How has Charles River Laboratories's deferred tax assets and other non-current assets changed year-over-year?
Charles River Laboratories's deferred tax assets and other non-current assets increased by 98.2% year-over-year, from $296.46M to $587.56M.
What is the long-term trend for Charles River Laboratories's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Charles River Laboratories's deferred tax assets and other non-current assets has grown at a 65.7% compound annual growth rate (CAGR), from $23.49M to $293.19M.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Charles River Laboratories's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude